Work

Ruxolitinib, a Janus Kinase (JAK)-1 and -2 Inhibitor Modulates Microrna (miR) Levels in Patients with Myelofibrosis (MF): miR Levels Might Predict MF Treatment Outcome

Year: 2011

Type: article

Source: Blood

DOI: 10.1182/blood.v118.21.1744.1744

Authors: Taghi Manshouri, Zeev Estrov, Liza Knez, Ying Zhang, Ross L Levine, Hagop M. Kantarjian, Srdan Verstovsek

Institutions: The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2552962559

FWCI:

Cites:

Cited by: 1

Related to: 10